News

Be Attuned to Extracutaneous Manifestations of Psoriasis

Publish date: March 4, 2011

 

EXPERT ANALYSIS FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGY

Dr. Mandell said that he has no relevant financial interests.

Pages

Recommended Reading

Explosion in Psoriasis Drug Development Promising
MDedge Dermatology
AAD: TNF Inhibitors for Psoriasis Linked to 48% Lower MI Risk
MDedge Dermatology
Acute Ischemia in Raynaud's Needs Urgent Care
MDedge Dermatology
Photodynamic Therapy Protocols Differ by Location
MDedge Dermatology
Don't Rule Out Off-Label Calcineurin Inhibitor Use, Says Expert
MDedge Dermatology
Capillaroscopy, Autoantibody Findings Predict Raynaud's Progression
MDedge Dermatology
AAD: Thalidomide Safe Second-Line Therapy for Cutaneous Lupus Erythematosus
MDedge Dermatology
Rash Pattern, Duration ID Hereditary Periodic Fever Syndromes
MDedge Dermatology
Know How to Steer Fast Biologics
MDedge Dermatology
Topical Steroids Found to Double Fetal Growth-Retardation Risk
MDedge Dermatology